HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pietro De Camilli Selected Research

synaptojanin

1/2022Presynaptic autophagy is coupled to the synaptic vesicle cycle via ATG-9.
1/2020Absence of Sac2/INPP5F enhances the phenotype of a Parkinson's disease mutation of synaptojanin 1.
12/2012Role of dynamin, synaptojanin, and endophilin in podocyte foot processes.
7/2008Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pietro De Camilli Research Topics

Disease

10Oculocerebrorenal Syndrome (Lowe Syndrome)
01/2019 - 07/2003
6Dent Disease
05/2017 - 05/2008
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2016 - 09/2005
3Neoplasms (Cancer)
12/2012 - 02/2004
2Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2020
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 07/2015
2Cataract (Cataracts)
01/2019 - 05/2008
2Parkinsonian Disorders (Parkinsonism)
01/2016 - 09/2013
2Seizures (Absence Seizure)
01/2016 - 02/2002
2Fanconi Syndrome (Syndrome, Fanconi)
05/2008 - 09/2007
2Intellectual Disability (Idiocy)
05/2008 - 09/2007
1Bites and Stings (Sting)
01/2022
1Nervous System Diseases (Neurological Disorders)
10/2018
1Hereditary Spastic Paraplegia
01/2017
1Congenital Structural Myopathies (Centronuclear Myopathy)
01/2017
1Drug Resistant Epilepsy
01/2016
1Epilepsy (Aura)
01/2016
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
07/2015
1Amyloid Plaque
07/2015
1Infections
07/2014
1Lymphopenia (Lymphocytopenia)
04/2014
1Crohn Disease (Crohn's Disease)
07/2013
1Immune System Diseases (Immune Disorders)
07/2013
1Rheumatoid Arthritis
07/2013
1Proteinuria
12/2012
1Obesity
04/2012
1Type 2 Diabetes Mellitus (MODY)
04/2012
1Stomach Neoplasms (Stomach Cancer)
12/2010
1Down Syndrome (Down's Syndrome)
07/2008
1Muscle Hypotonia (Hypotonia)
05/2008
1Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
09/2005
1Rhabdomyolysis
02/2004
1Rare Diseases (Rare Disease)
02/2004
1Muscle Rigidity
02/2004
1Breast Neoplasms (Breast Cancer)
02/2004
1Stiff-Person Syndrome (Stiff Man Syndrome)
02/2004
1Inborn Genetic Diseases (Disease, Hereditary)
07/2003

Drug/Important Bio-Agent (IBA)

8Inositol Polyphosphate 5-PhosphatasesIBA
01/2019 - 09/2007
7Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2007
4synaptojaninIBA
01/2022 - 07/2008
3ClathrinIBA
01/2022 - 08/2014
3Phosphatidylinositols (Phosphatidylinositol)IBA
09/2013 - 07/2003
2Amyloid (Amyloid Fibrils)IBA
01/2021 - 07/2015
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2016 - 04/2012
2epsinIBA
12/2012 - 12/2010
2amphiphysinIBA
02/2004 - 02/2002
1lipid transfer protein (glycolipid transfer protein)IBA
01/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1Mitochondrial DNA (mtDNA)IBA
01/2022
1Peptides (Polypeptides)IBA
01/2021
1LipidsIBA
10/2018
1Membrane LipidsIBA
10/2018
1Protons (Proton)IBA
05/2017
1ChloridesIBA
05/2017
1GTP Phosphohydrolases (GTPases)IBA
01/2017
1Biological ProductsIBA
01/2016
1Messenger RNA (mRNA)IBA
01/2016
1Membrane Proteins (Integral Membrane Proteins)IBA
07/2015
1Peptide Hydrolases (Proteases)FDA Link
07/2015
1Phenobarbital (Luminal)FDA Link
07/2015
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
07/2015
1Dynamin IIIBA
04/2014
1CytokinesIBA
07/2013
1Interleukin-12 (IL 12)IBA
07/2013
1apilimodIBA
07/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2012
1Inositol (Myoinositol)IBA
04/2012
1Histidine (L-Histidine)FDA Link
02/2010
1Phenylalanine (L-Phenylalanine)FDA Link
02/2010
1rho GTPase-activating proteinIBA
07/2009
1polyglutamineIBA
09/2005
1AntibodiesIBA
02/2004
1Protein Isoforms (Isoforms)IBA
02/2004
1AntigensIBA
02/2004

Therapy/Procedure

1Therapeutics
12/2012
1Immunotherapy
02/2004